Global Anisakiasis Treatment Market, By Treatment (Albendazole, Surgery, Others), Diagnosis (Endoscopy, Serologic Testing, Biopsy, Others), Dosage (Tablet, Suspension), Route of Administration (Oral, Others), Demographic (Adult, Pediatric, Geriatric), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights: Global Anisakiasis Treatment Market
Anisakiasis treatment market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 4% in the above mentioned forecast period.
Anisakiasis is human parasitic infection of the gastrointestinal tract which is caused due to the injection of larvae of nematodas Anisakis simplex or Pseudoterranova decipiens. It is present in fish or cephalopods. Symptoms of this infection include abdominal pain, vomiting and nausea. It is transmitted through the consumption of raw or uncooked fish that contains anisakis larvae. The larva is commonly present in the internal organs, flesh and muscles of cod, fluke, pacific salmon, herring, monkfish and flounder.
The major driver includes the more consumption of sea food such as raw fishes, octopus, sea lions and seals as they are the reservoir of the anisakis. Rise in the prevalence of this parasitic infection, growing healthcare expenditure, rising awareness about the existence of anisakid worms in fish are the major factors that will expand the anisakiasis treatment market. Rise in the research and development activities and emerging markets will provide beneficial opportunities for the anisakiasis treatment market in the forecast period of 2021-2028.
However, high cost associated with treatment, severe symptoms of the parasitic infection and less awareness among consumers as well as producers are the factors that will hinder the market growth and will further challenge the anisakiasis treatment market in the forecast period mentioned above.
This anisakiasis treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the anisakiasis treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Anisakiasis Treatment Market Scope and Market Size
The anisakiasis treatment market is segmented on the basis of treatment, diagnosis, dosage, route of administration, demographic, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of treatment, the anisakiasis treatment market is segmented into albendazole, surgery and others.
- On the basis of diagnosis, the anisakiasis treatment market is segmented into endoscopy, serologic testing, biopsy and others.
- On the basis of dosage, the anisakiasis treatment market is segmented into tablet and suspension.
- On the basis of route of administration, the anisakiasis treatment market is segmented into oral and others.
- On the basis of demographic, the anisakiasis treatment market is segmented into adult, pediatric and geriatric.
- On the basis of end-users, the anisakiasis treatment market is segmented into clinic, hospital and others.
The anisakiasis treatment market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.
Anisakiasis Treatment Market Country Level Analysis
Anisakiasis treatment market is analyzed and market size information is provided by the country, treatment, diagnosis, dosage, route of administration, demographic, end-users and distribution channel as referenced above.
The countries covered in the anisakiasis treatment market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
North America dominates the anisakiasis treatment market due to the presence of major key players, continuous technological development, well-developed healthcare sector and increasing prevalence of disease in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the increasing research and development activities, rising investment in the healthcare sector and growing government support.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Anisakiasis treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Global Anisakiasis Treatment Market Share Analysis
Anisakiasis treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to anisakiasis treatment market research.
The major players covered in the anisakiasis treatment market report are Supharma Chem, GlaxoSmithKline plc, SeQuent, Lasa Supergenerics Ltd., K.A.Malle Pharmaceuticals, LEO BIO-CARE PVT. LTD., Salius Pharma Private Limited., Fredun Group, Hubei Zhongjia-Chem Pharmaceutical Co., Ltd., Ashish Life Science, AdvaCare Pharma, Gonane Pharma, Aarambh life science, and Cipla Inc., among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-